Short-Term Outcomes of Acute Low-Tone Sensorineural Hearing Loss According to Treatment Modality
5
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background and Objectives: We compared improvements in hearing thresholds in acute low-tone sensorineural hearing loss (ALHL) patients after two different treatments: steroid alone and steroid and diuretic combined. We analyzed how the duration between the onset of symptoms and the initiation of treatment affected hearing loss improvement and investigated the relation between presence of vertigo in ALHL patients and ALHL progression to Ménière's disease (MD). Subjects and Methods: We retrospectively analyzed the medical records of 47 ALHL patients aged 21 to 76 years. Patients received either orally administered steroid alone (n=12) or steroid and diuretic combined (n=35). We compared improvements in the two groups’ hearing thresholds at three lower frequencies (125, 250, and 500 Hz) after participants had received one month of each respective treatment. Results: Our two treatments did not show any statistical difference in hearing loss improvement after one month. Forty percent of ALHL patients with vertigo developed MD, which was a significantly higher rate than the 12.5% of ALHL patients without vertigo who developed MD. The shorter duration between the onset of symptoms and the initiation of treatment significantly increased improvement in the sum of lower frequency hearing threshold after one month. Conclusions: The current study suggests that steroid and diuretic administered together and steroid alone similarly improve the hearing threshold in ALHL patients after one month. We concluded that patients should initiate ALHL treatment as soon as they experience symptoms. ALHL patients should also be notified of their higher risk of developing MD.
Abstract
Background and Objectives: We compared improvements in hearing thresholds in acute low-tone sensorineural hearing loss (ALHL) patients after two different treatments: steroid alone and steroid and diuretic combined. We analyzed how the duration between the onset of symptoms and the initiation of treatment affected hearing loss improvement and investigated the relation between presence of vertigo in ALHL patients and ALHL progression to Ménière's disease (MD). Subjects and Methods: We retrospectively analyzed the medical records of 47 ALHL patients aged 21 to 76 years. Patients received either orally administered steroid alone (n=12) or steroid and diuretic combined (n=35). We compared improvements in the two groups’ hearing thresholds at three lower frequencies (125, 250, and 500 Hz) after participants had received one month of each respective treatment. Results: Our two treatments did not show any statistical difference in hearing loss improvement after one month. Forty percent of ALHL patients with vertigo developed MD, which was a significantly higher rate than the 12.5% of ALHL patients without vertigo who developed MD. The shorter duration between the onset of symptoms and the initiation of treatment significantly increased improvement in the sum of lower frequency hearing threshold after one month. Conclusions: The current study suggests that steroid and diuretic administered together and steroid alone similarly improve the hearing threshold in ALHL patients after one month. We concluded that patients should initiate ALHL treatment as soon as they experience symptoms. ALHL patients should also be notified of their higher risk of developing MD.
참고문헌 (18)
- Imamura S, "Clinical observations on acute low-tone sensorineural hearing loss. Survey and analysis of 137 patients", Ann Otol Rhinol Laryngol, 106, pp.746~750 (1997)
- Abe T, "Acute sensorineural hearing loss in low tone frequencies", Otolaryngol Tokyo, 54, pp.385~392 (1982)
- Morita S, "A comparison of the short-term outcome in patients with acute low-tone sensorineural hearing loss", ORL J Otorhinolaryngol Relat Spec, 72, pp.295~299 (2010)
- Suzuki M, "Effect of corticosteroids or diuretics in low-tone sensorineural hearing loss", ORL J Otorhinolaryngol Relat Spec, 68, pp.170~176 (2006)
- Yamasoba T, "Acute low-tone sensorineural hearing loss without vertigo", Arch Otolaryngol Head Neck Surg, 120, pp.532~535 (1994)
- Aso S, "The intravenously administered glycerol test", Acta Otolaryngol Suppl, 504, pp.51~54 (1993)
- Merchant SN, "Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops?", Otol Neurotol, 26, pp.74~81 (2005)
- Nozawa I, "Clinical study of acute low-tone sensorineural hearing loss: survey and analysis of glycerol test and orthostatic test", Ann Otol Rhinol Laryngol, 111, pp.160~164 (2002)
- Yamasoba T, "An electrocochleographic study of acute low-tone sensorineural hearing loss", Eur Arch Otorhinolaryngol, 250, pp.418~422 (1993)
- Fuse T, "Immunological responses in acute low-tone sensorineural hearing loss and Ménière's disease", Acta Otolaryngol, 123, pp.26~31 (2003)
- Foster CA, "Endolymphatic hydrops in Ménière’s disease:cause, consequence, or epiphenomenon?", Otol Neurotol, 34, pp.1210~1214 (2013)
- Fuse T, "Shortterm outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid", ORL J Otorhinolaryngol Relat Spec, 64, pp.6~10 (2002)
- Fushiki H, "Prognosis of sudden low-tone loss other than acute low-tone sensorineural hearing loss", Acta Otolaryngol, 130, pp.559~564 (2010)
- 노경진, "Long-Term Outcomes of Acute Low-Tone Hearing Loss", Journal of Audiology & Otology, 19(2), pp.74~78 (2015), 대한청각학회
- Kanda K, "Effects of isosorbide in patients with Menière’s disease", Acta Otolaryngol Suppl, 504, pp.79~81 (1993)
- Nozawa I, "Efficacy of long-term administration of isosorbide for Ménière’s disease", ORL J Otorhinolaryngol Relat Spec, 57, pp.135~140 (1995)
- McCabe BF, "Autoimmune sensorineural hearing loss", Ann Otol Rhinol Laryngol, 88(5 Pt 1), pp.585~589 (1979)
- Hong SK, "Clinical observation on acute low-frequency hearing loss without vertigo:the role of cochlear hydrops analysis masking procedure as initial prognostic parameter", Ear Hear, 34, pp.229~235 (2013)